Добро пожаловать в клуб

Показать / Спрятать  Домой  Новости Статьи Файлы Форум Web ссылки F.A.Q. Логобург    Показать / Спрятать

       
Поиск   
Главное меню
ДомойНовостиСтатьиПостановка звуковФайлыКнижный мирФорумСловарьРассылкаКаталог ссылокРейтинг пользователейЧаВо(FAQ)КонкурсWeb магазинКарта сайта

Поздравляем!
Поздравляем нового Логобуржца Камелия со вступлением в клуб!

Реклама

КНИЖНЫЙ МИР

Solifenacin Vs Solifenacin+Duloxetine in Overactive Bladder Patients   Pratap Shankar,Anusha Vohra and Rakesh Kumar Dixit

Solifenacin Vs Solifenacin+Duloxetine in Overactive Bladder Patients

140 страниц. 2013 год.
LAP Lambert Academic Publishing
So many drugs are available in medicine market with promise to treat the problem of Overactive Bladder (OAB). Among all the drugs Solifenacin and Duloxetine are mostly prescribed by the physicians to treat the above problem. In this work, we compared the treatments by Solifenacin alone versus Solifenacin with Duloxetine with respect to efficacy, better safety profile and positive impact on quality of life in patients of OAB. This was an open, parallel, prospective and randomized trial and was carried out in outpatient of the Department of Medicine, Era’s Lucknow Medical College & Hospital, Lucknow, India and Department of Urology of Chatrapati Shahuji Maharaj Medical university (CSMMU) Lucknow, India. This study may be a very good reference for the medical students, researchers, teachers, scientists as well as the patients and may also be helpful in eradication of the overactive bladder problem which cause the risk of bladder cancer.
 
- Генерация страницы: 0.04 секунд -